Attention AACR Annual Meeting 2018 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 128
Introduction: Epigenetic-driven cancers: challenges and opportunities
Nada Jabado
McGill Univ., Montréal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Histone H3 variants and human cancer
Peter W Lewis
University of Wisconsin-Madison, Madison, WI, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Subgroup-specific enhancer hijacking in medulloblastoma
Paul A Northcott
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Deregulation of H3K36 methylation pathways in cancer
Chao Lu
Columbia University, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Epigenetic dysregulation and mutational partnerships in pediatric glioma
Jacek Majewski
McGill University and Genome Quebec Innovation Centre, Montreal, QC, Canada
from AACR Annual Meeting 2018 on April 14, 2018 1:00 PM-3:00 PM
Invited Speaker
Dmitry I Gabrilovich
The Wistar Institute, Philadelphia, PA, United States
from AACR Annual Meeting 2018 on April 15, 2018 7:00 AM-8:00 AM
Prevention in the context of pediatric cancer: Improving outcomes in survivors
Lisa R Diller
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Prevention of late effects: Can we learn from laboratory models?
Jason N Berman
IWK Health Ctr., Halifax, NS, Canada
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Prevention of late toxicity using clinical trials: Chemoprevention of late congestive heart failure
Saro Armenian
City of Hope, Duarte, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Risk of second malignancy cancer after childhood and adolescent cancer: Does epidemiology inform risk reduction strategy?
Flora E. van Leeuwen
Netherlands Cancer Institute, Amsterdam, Netherlands
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Driver mutations in chromatin modifiers in medulloblastoma and their potential therapeutic implications
Stefan M Pfister
German Cancer Research Ctr., Heidelberg, Germany
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Polycomb dysregulation by oncohistones
Peter W Lewis
University of Wisconsin, Madison, WI, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Transforming chromatin: Oncogenic histone H3 in diffuse intrinsic pontine gliomas
Suzanne J Baker
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Cancer cachexia: A definition and neuroscience perspective
Daniel Marks
Oregon Health & Science University, Portland, OR, United States
from AACR Annual Meeting 2018 on April 17, 2018 5:00 PM-6:30 PM
Molecular mechanisms of muscle wasting in cancer
Denis C Guttridge
Ohio State University Medical Center, Columbus, OH, United States
from AACR Annual Meeting 2018 on April 17, 2018 5:00 PM-6:30 PM
Recent clinical trial findings and identification of new therapeutic targets
Marion Everett Couch
Indiana Univ. School of Medicine, Indianapolis, IN, United States
from AACR Annual Meeting 2018 on April 17, 2018 5:00 PM-6:30 PM
Panel Discussion
Laleh Amiri-Kordestani
FDA, Silver Spring, MD, United States
Javid M. Moslehi
Vanderbilt Univ. School of Medicine, Nashville, TN, United States
George D. Demetri
Dana-Farber Cancer Inst. and Harvard Med, Boston, MA, United States
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
David Feltquate
Bristol-Myers Squibb, New York, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
Shiv Pillai
Harvard Medical School, Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Invited Speaker
Suzanne L. Topalian
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 1, 2017 1:00 PM-2:45 PM
Chair
Robert J. Gillies
Moffitt Cancer Center & Research Institute, Tampa, FL, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Tumor immune-pathology from the molecular scale on up
Garry P. Nolan
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
To image and imagine: Molecular imaging and theranostics of cancer
Zaver M. Bhujwalla
Johns Hopkins Univ. School of Medicine, Baltimore, MD, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Imaging tumor habitats: Life at the edge
Robert J. Gillies
Moffitt Cancer Center & Research Institute, Tampa, FL, United States
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
Tumor-associated myelomonocytic cells as therapeutic targets
Alberto Mantovani
Humanitas University, Rozzano, Milano, Italy
from AACR Annual Meeting 2017 on April 2, 2017 1:00 PM-2:45 PM
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 128